메뉴 건너뛰기




Volumn 73, Issue 7, 2007, Pages 990-1000

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment

Author keywords

Chemotherapy; Gastric cancer; RUNX3; Vorinostat

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; TRANSCRIPTION FACTOR RUNX3; VORINOSTAT;

EID: 33847228395     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.013     Document Type: Article
Times cited : (29)

References (40)
  • 1
    • 0037372003 scopus 로고    scopus 로고
    • Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
    • Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 (2003) 245-254
    • (2003) Nat Genet , vol.33 , pp. 245-254
    • Jaenisch, R.1    Bird, A.2
  • 2
    • 0346888538 scopus 로고    scopus 로고
    • The epigenome as a target for cancer chemoprevention
    • Kopelovich L., Crowell J.A., and Fay J.R. The epigenome as a target for cancer chemoprevention. J Natl Cancer Inst 95 23 (2003) 1747-1757
    • (2003) J Natl Cancer Inst , vol.95 , Issue.23 , pp. 1747-1757
    • Kopelovich, L.1    Crowell, J.A.2    Fay, J.R.3
  • 4
    • 0037169358 scopus 로고    scopus 로고
    • Apoptosis: a link between cancer genetics and chemotherapy
    • Johnstone R.W., Ruefli A.A., and Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108 (2002) 153-164
    • (2002) Cell , vol.108 , pp. 153-164
    • Johnstone, R.W.1    Ruefli, A.A.2    Lowe, S.W.3
  • 5
    • 0642286534 scopus 로고    scopus 로고
    • Protein deacetylases: enzymes with functional diversity as novel therapeutic targets
    • Yoshida M., Shimazu T., and Matsuyama A. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets. Prog Cell Cycle Res 5 (2003) 269-278
    • (2003) Prog Cell Cycle Res , vol.5 , pp. 269-278
    • Yoshida, M.1    Shimazu, T.2    Matsuyama, A.3
  • 6
    • 0141988610 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: the Abbott experience
    • Curtin M., and Glaser K. Histone deacetylase inhibitors: the Abbott experience. Curr Med Chem 10 22 (2003) 2373-2392
    • (2003) Curr Med Chem , vol.10 , Issue.22 , pp. 2373-2392
    • Curtin, M.1    Glaser, K.2
  • 7
    • 0141885036 scopus 로고    scopus 로고
    • Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation
    • Delorme B.A. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation. Curr Med Chem 10 22 (2003) 2359-2372
    • (2003) Curr Med Chem , vol.10 , Issue.22 , pp. 2359-2372
    • Delorme, B.A.1
  • 9
    • 0141953928 scopus 로고    scopus 로고
    • The discovery of NVP-LAQ824: from concept to clinic
    • Remiszewski S. The discovery of NVP-LAQ824: from concept to clinic. Curr Med Chem 10 22 (2003) 2393-2402
    • (2003) Curr Med Chem , vol.10 , Issue.22 , pp. 2393-2402
    • Remiszewski, S.1
  • 10
    • 2942659322 scopus 로고    scopus 로고
    • Oncogenic potential of the RUNX gene family: 'overview'
    • Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23 24 (2004) 4198-4208
    • (2004) Oncogene , vol.23 , Issue.24 , pp. 4198-4208
    • Ito, Y.1
  • 11
    • 0030666372 scopus 로고    scopus 로고
    • Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
    • Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
    • (1997) Cell , vol.89 , pp. 765-771
    • Otto, F.1    Thornell, A.P.2    Crompton, T.3    Denzel, A.4    Gilmour, K.C.5    Rosewell, I.R.6
  • 12
    • 18344389720 scopus 로고    scopus 로고
    • Causal relationship between the loss of RUNX3 expression and gastric cancer
    • Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 1 (2002) 113-124
    • (2002) Cell , vol.109 , Issue.1 , pp. 113-124
    • Li, Q.L.1    Ito, K.2    Sakakura, C.3    Fukamachi, H.4    Inoue, K.5    Chi, X.Z.6
  • 13
    • 24744470103 scopus 로고    scopus 로고
    • RUNX3, a novel tumor suppressor, is highly inactivated in gastric cancer by protein mislocalization
    • Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., et al. RUNX3, a novel tumor suppressor, is highly inactivated in gastric cancer by protein mislocalization. Cancer Res 65 (2005) 7743-7750
    • (2005) Cancer Res , vol.65 , pp. 7743-7750
    • Ito, K.1    Liu, Q.2    Salto-Tellez, M.3    Yano, T.4    Tada, K.5    Ida, H.6
  • 14
    • 24344500170 scopus 로고    scopus 로고
    • RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD
    • Chi X.Z., Yang J.O., Lee K.Y., Ito K., Sakakura C., Li Q.L., et al. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25 18 (2005) 8097-8107
    • (2005) Mol Cell Biol , vol.25 , Issue.18 , pp. 8097-8107
    • Chi, X.Z.1    Yang, J.O.2    Lee, K.Y.3    Ito, K.4    Sakakura, C.5    Li, Q.L.6
  • 15
    • 33746121227 scopus 로고    scopus 로고
    • RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer
    • Lau Q.C., Raja E., Salto-Tellez M., Liu Q., Ito K., Inoue M., et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 66 13 (2006) 6512-6520
    • (2006) Cancer Res , vol.66 , Issue.13 , pp. 6512-6520
    • Lau, Q.C.1    Raja, E.2    Salto-Tellez, M.3    Liu, Q.4    Ito, K.5    Inoue, M.6
  • 16
    • 22944435843 scopus 로고    scopus 로고
    • RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer
    • Imamura Y., Hibi K., Koike M., Fujiwara M., Kodera Y., Ito K., et al. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer. Anticancer Res 25 4 (2005) 2627-2630
    • (2005) Anticancer Res , vol.25 , Issue.4 , pp. 2627-2630
    • Imamura, Y.1    Hibi, K.2    Koike, M.3    Fujiwara, M.4    Kodera, Y.5    Ito, K.6
  • 18
    • 24944523611 scopus 로고    scopus 로고
    • Hypermethylation of the RUNX3 gene in hepatocellular carcinoma
    • Park W.S., Cho Y.G., Kim C.J., Song J.H., Lee Y.S., Kim S.Y., et al. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 37 4 (2005) 276-281
    • (2005) Exp Mol Med , vol.37 , Issue.4 , pp. 276-281
    • Park, W.S.1    Cho, Y.G.2    Kim, C.J.3    Song, J.H.4    Lee, Y.S.5    Kim, S.Y.6
  • 19
    • 1142275110 scopus 로고    scopus 로고
    • Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia
    • Kang G.H., Lee S., Lee H.J., and Hwang K.S. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 202 2 (2004) 233-240
    • (2004) J Pathol , vol.202 , Issue.2 , pp. 233-240
    • Kang, G.H.1    Lee, S.2    Lee, H.J.3    Hwang, K.S.4
  • 20
    • 0034176015 scopus 로고    scopus 로고
    • HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance
    • Ruefli A.A., Smyth S.M., and Johnstone R.W. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95 7 (2000) 2378-2385
    • (2000) Blood , vol.95 , Issue.7 , pp. 2378-2385
    • Ruefli, A.A.1    Smyth, S.M.2    Johnstone, R.W.3
  • 21
    • 0029693220 scopus 로고    scopus 로고
    • The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation
    • Van Lint C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gen Express 5 (1996) 245-253
    • (1996) Gen Express , vol.5 , pp. 245-253
    • Van Lint, C.1    Emiliani, S.2    Verdin, E.3
  • 22
    • 0035046529 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
    • Richon V.M., Zhou X., Rifkind R.A., and Marks P.A. Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. Blood Cells Mol Dis 27 (2001) 260-264
    • (2001) Blood Cells Mol Dis , vol.27 , pp. 260-264
    • Richon, V.M.1    Zhou, X.2    Rifkind, R.A.3    Marks, P.A.4
  • 23
    • 2942755609 scopus 로고    scopus 로고
    • Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia
    • Romanski A., Bacic B., Bug G., Preifer H., Gul H., Remiszewski S., et al. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. Haematologica 89 (2004) 419-426
    • (2004) Haematologica , vol.89 , pp. 419-426
    • Romanski, A.1    Bacic, B.2    Bug, G.3    Preifer, H.4    Gul, H.5    Remiszewski, S.6
  • 24
    • 12644307234 scopus 로고    scopus 로고
    • Functional dissection of the α and β subunits of transcription factor PEBP2 and the Redox susceptibility of Its DNA binding activity
    • Kagoshima H., Akamatsu Y., Ito Y., and Shigesada K. Functional dissection of the α and β subunits of transcription factor PEBP2 and the Redox susceptibility of Its DNA binding activity. J Biol Chem 20;271 51 (1996) 33074-33082
    • (1996) J Biol Chem , vol.20 271 , Issue.51 , pp. 33074-33082
    • Kagoshima, H.1    Akamatsu, Y.2    Ito, Y.3    Shigesada, K.4
  • 25
    • 0035962632 scopus 로고    scopus 로고
    • DNA methylation, chromatin inheritance, and cancer
    • Rountree M.R., Bachman K.E., Herman J.G., and Baylin S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 20 24 (2001) 3156-3165
    • (2001) Oncogene , vol.20 , Issue.24 , pp. 3156-3165
    • Rountree, M.R.1    Bachman, K.E.2    Herman, J.G.3    Baylin, S.B.4
  • 26
    • 0035943709 scopus 로고    scopus 로고
    • Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin
    • Bachman K.E., Rountree M.R., and Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 276 34 (2001) 32282-32287
    • (2001) J Biol Chem , vol.276 , Issue.34 , pp. 32282-32287
    • Bachman, K.E.1    Rountree, M.R.2    Baylin, S.B.3
  • 27
    • 0033919595 scopus 로고    scopus 로고
    • DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
    • Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., and Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25 (2000) 338-342
    • (2000) Nat Genet , vol.25 , pp. 338-342
    • Robertson, K.D.1    Ait-Si-Ali, S.2    Yokochi, T.3    Wade, P.A.4    Jones, P.L.5    Wolffe, A.P.6
  • 28
    • 0032948005 scopus 로고    scopus 로고
    • Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
    • Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21 1 (1999) 103-107
    • (1999) Nat Genet , vol.21 , Issue.1 , pp. 103-107
    • Cameron, E.E.1    Bachman, K.E.2    Myohanen, S.3    Herman, J.G.4    Baylin, S.B.5
  • 29
    • 0037427805 scopus 로고    scopus 로고
    • Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2′-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells
    • Primeau M., Gagnon J., and Momparler R.L. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2′-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells. Int J Cancer 103 2 (2003) 177-184
    • (2003) Int J Cancer , vol.103 , Issue.2 , pp. 177-184
    • Primeau, M.1    Gagnon, J.2    Momparler, R.L.3
  • 30
    • 0037310863 scopus 로고    scopus 로고
    • RUNX transcription factors as key targets of TGF-β superfamily signaling
    • Ito Y., and Miyazono K. RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev 13 (2003) 43-47
    • (2003) Curr Opin Genet Dev , vol.13 , pp. 43-47
    • Ito, Y.1    Miyazono, K.2
  • 31
    • 0028168242 scopus 로고
    • INK4B is a potential effector of TGF-beta-induced cell cycle arrest
    • INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371 (1994) 257-261
    • (1994) Nature , vol.371 , pp. 257-261
    • Hannon, G.J.1    Beach, D.2
  • 32
    • 0029153609 scopus 로고
    • Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
    • Reynisdottir I., Polyak K., Iavarone A., and Massague J. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9 (1995) 1831-1845
    • (1995) Genes Dev , vol.9 , pp. 1831-1845
    • Reynisdottir, I.1    Polyak, K.2    Iavarone, A.3    Massague, J.4
  • 33
    • 0037562075 scopus 로고    scopus 로고
    • Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation
    • Koeller K.M., Haggarty S.J., Perkins B.D., Leykin L., Wong J.C., Kao M.C., et al. Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. Chem Biol 10 5 (2003) 397-410
    • (2003) Chem Biol , vol.10 , Issue.5 , pp. 397-410
    • Koeller, K.M.1    Haggarty, S.J.2    Perkins, B.D.3    Leykin, L.4    Wong, J.C.5    Kao, M.C.6
  • 34
    • 0034816579 scopus 로고    scopus 로고
    • Transcriptional activation of p21WAF1/CIP1 by Apicidin, a novel histone deacetylase inhibitor
    • Kim J.S., Lee S., Lee T., Trepel J.B., and Lee Y.-W. Transcriptional activation of p21WAF1/CIP1 by Apicidin, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun 281 (2001) 866-871
    • (2001) Biochem Biophys Res Commun , vol.281 , pp. 866-871
    • Kim, J.S.1    Lee, S.2    Lee, T.3    Trepel, J.B.4    Lee, Y.-W.5
  • 35
    • 14844353574 scopus 로고    scopus 로고
    • Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors
    • Peart M.J., Smyth G.K., van Laar R.K., Bowtell D.D., Richon V.M., Marks P.A., et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci USA 102 10 (2005) 3697-3702
    • (2005) Proc Natl Acad Sci USA , vol.102 , Issue.10 , pp. 3697-3702
    • Peart, M.J.1    Smyth, G.K.2    van Laar, R.K.3    Bowtell, D.D.4    Richon, V.M.5    Marks, P.A.6
  • 36
    • 0035845541 scopus 로고    scopus 로고
    • The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species
    • Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci USA 98 19 (2001) 10833-10838
    • (2001) Proc Natl Acad Sci USA , vol.98 , Issue.19 , pp. 10833-10838
    • Ruefli, A.A.1    Ausserlechner, M.J.2    Bernhard, D.3    Sutton, V.R.4    Tainton, K.M.5    Kofler, R.6
  • 37
    • 0038485588 scopus 로고    scopus 로고
    • Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA)
    • Henderson C., Mizzau M., Paroni G., Maestro R., Schneider C., and Brancolini C. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278 14 (2003) 12579-12589
    • (2003) J Biol Chem , vol.278 , Issue.14 , pp. 12579-12589
    • Henderson, C.1    Mizzau, M.2    Paroni, G.3    Maestro, R.4    Schneider, C.5    Brancolini, C.6
  • 38
    • 33745018595 scopus 로고    scopus 로고
    • The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis
    • Yano T., Ito K., Fukamachi H., Chi X.Z., Wee H.J., Inoue K., et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26 12 (2006) 4474-4488
    • (2006) Mol Cell Biol , vol.26 , Issue.12 , pp. 4474-4488
    • Yano, T.1    Ito, K.2    Fukamachi, H.3    Chi, X.Z.4    Wee, H.J.5    Inoue, K.6
  • 39
    • 33646189483 scopus 로고    scopus 로고
    • RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells
    • Yamamura Y., Lee W.L., Inoue K., Ida H., and Ito Y. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J Biol Chem 281 8 (2006) 5267-5276
    • (2006) J Biol Chem , vol.281 , Issue.8 , pp. 5267-5276
    • Yamamura, Y.1    Lee, W.L.2    Inoue, K.3    Ida, H.4    Ito, Y.5
  • 40
    • 0033367018 scopus 로고    scopus 로고
    • Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)
    • Cohen L.A., Amin S., Marks P.A., Rifkind R.A., Desai D., and Richon V.M. Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res 19 6B (1999) 4999-5005
    • (1999) Anticancer Res , vol.19 , Issue.6 B , pp. 4999-5005
    • Cohen, L.A.1    Amin, S.2    Marks, P.A.3    Rifkind, R.A.4    Desai, D.5    Richon, V.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.